3 Aging, Arterial Stiffness,
|
|
- Aldous Sharp
- 6 years ago
- Views:
Transcription
1 Chapter 3 / Mechanisms of Hypertension 23 3 Aging, Arterial Stiffness, and Systolic Hypertension Joseph L. Izzo, Jr., MD CONTENTS INTRODUCTION POPULATION STUDIES PATHOPHYSIOLOGY NONINVASIVE MEASUREMENT OF ARTERIAL STIFFNESS REFERENCES INTRODUCTION Within the past few years, the paradigm in hypertension has shifted from an emphasis on diastolic blood pressure (DBP) to one that emphasizes the importance of systolic blood pressure (SBP), especially in individuals over age 50 years (1 4). The rationale for this shift is based on a large body of observational and clinical trial data demonstrating that SBP is a better risk predictor, and that SBP control markedly reduces cardiovascular morbidity and mortality. At the same time, there has been relatively little information available to practitioners about the many new concepts that underlie this new approach to cardiovascular pathophysiology. Most important is the notion that age-related changes in vascular stiffness are at the center of future efforts to provide important new diagnostic and therapeutic advances in hypertension care. From: Clinical Hypertension and Vascular Diseases: Hypertension in the Elderly Edited by: L. M. Prisant Humana Press Inc., Totowa, NJ 23
2 24 Hypertension in the Elderly Fig. 1. Mean systolic and diastolic blood pressures (BPs) by age and race/ ethnicity for men and women, US population 18 years old. (From ref. 5.) POPULATION STUDIES Age, Blood Pressure, and Cardiovascular Risk Cross-sectional population studies showed that SBP increases throughout life, whereas DBP increases until about age 50 years and then declines in men and women and in all racial groups (5) (Fig. 1). Of interest, the relationship of age and SBP is only found in complex industrialized societies; primitive peoples and cloistered groups such as nuns or institutionalized people do not experience this effect. By age 60 years, about two-thirds of those with hypertension have isolated systolic hypertension (ISH); by age 75 years, almost all hypertensives have systolic hypertension, and about three-fourths of hypertensives have ISH (3). It is now widely recognized that the risk of cardiovascular diseases (CVDs) in individuals beyond 50 years of age is best predicted by SBP (1-4,6). In fact, some studies in individuals 50 to 79 years of age suggested that the risk of coronary artery disease is inversely related to DBP at any given level of SBP. Wide pulse pressure (PP; PP = SBP DBP) has been found to be an independent predictor of CVD risk in people over 60 years of age, even after adjusting for previous clinical CVD, age, gender, and other cardinal risk factors (7). PP is a stronger predictor of CVD risk in those with dyslipidemia, left ventricular hypertrophy (LVH), albuminuria, chronic kidney disease, or prior cardiovascular events (myocardial infarction, ventricular dysfunction, or heart failure) (8 10).
3 Chapter 3 / Mechanisms of Hypertension 25 Yet, there are important limitations to using PP as a reliable risk indicator. In middle-aged, healthy populations or older individuals with both systolic and diastolic hypertension, any blood pressure (BP) component (systolic, diastolic, or mean arterial pressure [MAP]) may be equal or superior to PP as a risk predictor (6). Impact on Classification of Hypertension There are important implications of aging effects on the value of SBP and DBP as diagnostic indices in hypertension. After age 50 years, SBP becomes more reliable in the classification of hypertension and in risk stratification, as was shown in the Framingham Heart Study (11). By convention, when both SBP and DBP are considered, the higher value determines the correct stage of hypertension. For example, using the current classification system, a person with a BP of 162/90 mmhg would be classified as having stage 2 hypertension because the 162 mmhg exceeds the threshold for stage 2 hypertension (>160 mmhg) and thus upstages the diastolic value (which would by itself be considered stage 1). When used as the sole classifier of the stage of hypertension, SBP is accurate more than 90% of the time, whereas the diastolic value accurately predicts the stage of hypertension only about 60% (11). Benefits of SBP Control The best study conducted in systolic hypertension is the Systolic Hypertension in the Elderly Program, a 4-year intervention that included 4694 individuals over age 60 with pretreatment SBP over 160 and DBP under 90 mmhg. Compared to placebo, individuals treated with chlorthalidone (with or without β-blocker) achieved favorable benefits in the primary end point of stroke ( 36%), as well as reductions in heart failure events ( 54%), myocardial infarctions ( 27%), and overall CVD events ( 32%) (12). Using a similar design and sample size, the Systolic Hypertension in Europe trial compared a regimen based on nitrendipine (a dihydropyridine calcium antagonist) to a placebo-based regimen and found a significant benefit on stroke ( 41%) as well as overall CVD events ( 31%) (13). A meta-analysis of eight placebo-controlled trials in 15,693 elderly patients followed for 4 years found that active antihypertensive treatment reduced coronary events (23%), strokes (30%), cardiovascular deaths (18%), and total deaths (13%), with the benefit particularly high in those older than 70 years of age (14). Most experts now feel that the choice of initial agent is less important than the level of BP reduction achieved (4,15).
4 26 Hypertension in the Elderly PATHOPHYSIOLOGY Why is there such a great benefit of treating systolic hypertension? The answer becomes clearer after a review of basic cardiovascular pathophysiology. Although it is currently fashionable to describe hypertension as a complex metabolic syndrome that involves insulin resistance and other derangements; in the main, hypertension remains a hemodynamic syndrome with properties that change with age. Steady-State Hemodynamics Basic teaching of the hemodynamics of hypertension has historically ignored the intrinsic pulsatility of the circulation. Typically, a steadystate flow model has been used to approximate circulatory hemodynamics, and MAP has been used as a surrogate for systemic vascular resistance (SVR) and the integrated pressure burden on the vasculature. MAP is analogous to voltage in the electrical steady-state model (Ohm s law), where Voltage = Current Resistance. Thus, MAP = Total flow (Cardiac output) SVR. In this simplified model, MAP is more closely related to DBP than SBP. Parallel increases in SBP and DBP up to age 50 years are primarily the result of age-related increases in SVR, but it is common to find systolic hypertension associated with increased cardiac stroke volume in younger hypertensives (16). Pulsatility and Blood Flow To understand the pathophysiological relevance of systolic hypertension, it is necessary to review the physiology of circulatory pulsatility. In conjunction with cardiac contraction, the arterial system serves two basic interrelated functions: conveyance of a sufficient quantity of blood to various tissues (the conduit function) and damping of pulsatile flow to provide a smoother flow profile in the microcirculation. The pulsatile or dynamic component of blood pressure is the summation of three major factors: cardiac contractility (stroke volume), aortic impedance (central arterial stiffness), and late systolic pressure augmentation caused by pulse wave reflection from the distal circulation (Fig. 2). Central Arterial Stiffness Large central arteries, predominantly the thoracic aorta and its proximal branches, fulfill the damping function by expanding during systole, storing some but not all of each stroke volume, and utilizing elastic recoil to propel the residual of each stroke volume to the periphery during diastole. The resulting damping of pulsatility in normal young arteries creates a relatively narrow PP (Fig. 3). When central arteries are stiffer,
5 Chapter 3 / Mechanisms of Hypertension 27 Fig. 2. Components of blood pressure (BP) and cardiac load. Various parameters are needed to describe pulsatile phenomena. DN, dicrotic notch, the division between systole and diastole. Left-hand panel demonstrates a typical aortic pulse contour in an individual with hypertension. Pulse pressure (PP) represents the maximal difference between systolic BP (SBP) and diastolic BP (DBP); mean arterial pressure (MAP) = DBP + 1/3 PP. Major components of PP include (a) cardiac stroke volume, (b) aortic impedance to early systolic outflow, and (c) late systolic augmentation pressure (AP) caused by arterial stiffening and premature return of reflected waves. Total cardiac load, the integral of the systolic pulse contour, depends mainly on the interactions of three factors proportionally represented by the bar graph at the right: DBP, coupled effects of ventricular contraction and aortic impedance, and AP. two related events occur: (a) SBP increases because more blood is delivered to the periphery during systole, and (b) DBP decreases because there is less residual stroke volume to be delivered to the periphery during diastole. Thus, central arterial stiffness causes PP to increase, a phenomenon that is independent of any change in MAP. The cellular basis of age-related arterial stiffening is only partly understood. The elastic behavior of arteries depends primarily on the composition and arrangement of collagen, elastin, and vascular smooth muscle cells in the tunica media of the arterial wall. An elastin matrix attached to vascular smooth muscle cells acts to damp changes in intraluminal pressure and tension. There is a functional dependency of arterial wall tension and stiffness on the distending pressure; increased BP stretches the load-bearing elastic lamellae, making the arteries functionally stiffer. Over a lifetime, other structural changes occur, including loss of elastin and increased collagen deposition. This degenerative process is some-
6 28 Hypertension in the Elderly Fig. 3. Effect of central arterial stiffness on pulse pressure (PP). Age-related increases in central arterial stiffness convert a smooth peripheral pressure wave with a narrow PP to a more pulsatile peripheral pressure wave with increased PP. Changes in PP are independent of changes in stroke volume or systemic vascular resistance. The central problem is the loss of aortic elasticity; systolic pressure is increased and diastolic blood pressure (BP) is decreased because of the loss of elastic recoil of the aorta. (Adapted from ref. 26.) times called arteriosclerosis to differentiate it from atherosclerosis, the occlusive result of endovascular inflammatory disease caused by lipid oxidation and plaque formation. Hypertension, diabetes, and chronic renal failure accelerate the aging of central elastic arteries and cause premature arterial stiffening. Reflection, Augmentation, and Amplification A fundamental property of stiff arteries is that they conduct pulse waves faster than more elastic vessels. Arterial stiffness thus can be approximated by measuring pulse wave velocity (PWV). Another fundamental property of pulse wave transmission is that pulse waves can be reflected within arterial walls, leading to both forward and backward transmission of pulse waves (17) (Fig. 4). Reflected waves have their origins at points of impedance mismatch, where the flow and pressure waves are not perfectly matched, especially from branch points, constrictions, or areas of turbulence.
7 Chapter 3 / Mechanisms of Hypertension 29 Fig. 4. Components of arterial pulse waves in older and younger subjects. Because of the property of wave reflection, any pulse wave can be decomposed into a forward-traveling and backward-traveling wave. The velocity of travel of these pulse waves (PWV) is directly proportional to the stiffness of the arterial wall. In older people, increased PWV causes early return of the principal reflected wave, which summates with the incident wave to augment late systolic pressure. Vertical line is the dicrotic notch that separates systole from diastole. (Modified from ref. 17.) Wave reflection can have important effects on cardiac function and structure. In young people with elastic arteries, the primary reflected wave returns to the aortic root during early diastole, where it serves to augment coronary artery filling. In older people with stiffer arteries, the high PWV causes the primary reflected wave to return to the aortic root before the end of systole, where it summates with the forward-traveling pulse wave and augments late SBP (Fig. 4). Another interesting and poorly understood property of the arterial tree is PP amplification (18) (Fig. 5). In normal young individuals with highly elastic arterial walls, PP at distal arterial sites is greater than that measured centrally. This contrasts with MAP, which is relatively constant throughout the arterial tree. PP amplification is the result of the progressive increase in impedance that occurs in the distal circulation and the corresponding differences in the summation of incident and reflected waves along the arterial tree. In normal young people, it is not uncom-
8 30 Hypertension in the Elderly Fig. 5. Pulse pressure (PP) amplification and wave reflection. In normal young individuals, PP is amplified as the wave travels downstream because of a progressive increase in impedance, and mean arterial pressure remains constant. With age and increased central pressure augmentation, the difference between central and peripheral PP decreases. Thus, peripheral PP is not always equivalent to central PP. (From ref. 27.) mon to observe a brachial PP that is 20 to 30 mmhg higher than that at the aortic root. With aging, however, the greater magnitude of the reflected waves and the increased PWV contribute to a progressive diminution of the apparent central peripheral PP differential (Fig. 5). The importance of this effect is that brachial SBP (or PP) is not always a reliable surrogate for central SBP (19). The Integrated Hemodynamic Model Age-related increases in SBP and widening of PP usually signify that arterial stiffness has become the dominant hemodynamic lesion. There remains a role for excessive vasoconstriction in the syndrome of hypertension, however, because systemic vasoconstriction and increased SVR contribute to both systolic and diastolic hypertension (Fig. 6). Overall, increased SBP can be the result of increases in stroke volume, arterial stiffness, or SVR, whereas DBP is decreased when central arterial stiffness increases. DBP thus varies directly with SVR and inversely with central arterial stiffness. The ability of increased SVR to cause increases in either SBP or DBP (depending on the degree of central arterial stiffness) causes otherwise unexpected differences in the therapeutic responses of SBP and DBP to
9 Chapter 3 / Mechanisms of Hypertension 31 Fig. 6. Integrated hemodynamic model of hypertension. Factors promoting increased systolic blood pressure (BP) are increased cardiac contractility (stroke volume), increased central arterial stiffness, and increased arteriolar constriction (systemic vascular resistance). Peripheral arteriolar constriction directly increases diastolic BP and mean arterial pressure, whereas central artery stiffness lowers diastolic BP. Fig. 7. Effect of arterial stiffness on BP responses to vasodilation. The net effect of an arteriolar dilator drug on systolic and diastolic BP can be very different depending on the stiffness of an individual s central arteries. For the same degree of vasodilation, an individual with stiff arteries and isolated systolic hypertension (ISH) will respond with a marked reduction in systolic BP (-20/ -5 mmhg = -10 mmhg MAP), whereas an individual with isolated diastolic hypertension will experience a predominant effect on diastolic BP ( 6/ 12 mmhg = 10 mmhg MAP). (Modified from ref. 20.) vasodilators (20). In ISH, a vasodilator causes a disproportionate drop in SBP; the same vasodilator in a person with diastolic hypertension decreases DBP. If both SBP and DBP are elevated, both will be decreased by the vasodilator therapy (Fig. 7).
10 32 Hypertension in the Elderly Fig. 8. Effect of age and central pressure augmentation on cardiac load. Increased arterial stiffness causes increased pulse wave velocity and promotes late systolic pressure augmentation. Augmentation index increases with age, but this effect is accelerated by the presence of hypertension. Increased late systolic pressure contributes to the overall cardiac load and can be considered wasted cardiac work. Increased cardiac load contributes directly to left ventricular hypertrophy. Pathological Implications Systolic hypertension and increased PP are strong surrogate markers for CVD morbidity and mortality. Increased pulsatile load is the major factor in increased left ventricular systolic wall stress and LVH, both of which impair left ventricular relaxation and contribute to diastolic dysfunction. Increased ventricular mass increases coronary blood flow requirements and decreases coronary flow reserve. Late systolic pressure augmentation further increases ventricular load; in elderly persons with ISH, late systolic pressure can be increased by as much as 20 to 40 mmhg as a result of wave reflection. In general, central systolic augmentation is age dependent and contributes to wasted cardiac output and LVH (Fig. 8). Simultaneously, as PP widens, decreases in DBP further compromise coronary filling. At the same time, greater shear stress on the central arteries accentuates aortic, carotid, and coronary atherosclerosis and probably contributes to rupture of unstable atherosclerotic plaques. The distal vasculature is also affected because increased pulsatile stress promotes endothelial dysfunction, thus affecting the balance in the forces controlling arteriolar constriction and dilation and favoring arteriolar smooth muscle hypertrophy and arteriolar remodeling.
11 Chapter 3 / Mechanisms of Hypertension 33 NONINVASIVE MEASUREMENT OF ARTERIAL STIFFNESS As discussed in this review, information related to the assessment of SBP, PP, and central arterial stiffness is fundamentally different from that related to DBP or MAP. Thus, the elastic properties of the arteries and the impact of arterial stiffness on pulse wave transmission and reflection are of increasing interest to researchers and clinicians. Because brachial PP is only loosely related to central PP and wide PP in general is a late indicator of CVD risk, many investigators are searching for more sensitive measures of earlier changes in arterial wall properties. Changes in central artery stiffness can be quantitated using research methods that measure PWV, aortic impedance, and analysis of arterial waveform morphology. Increased PWV has been correlated with increased CVD mortality (21), and aortic impedance can be affected differently by different antihypertensive agents (22). In the future, it may be possible to use these indicators of central artery stiffness to allow targeted primary prevention of CVD or improved therapeutic monitoring of antihypertensive drugs or new compounds that directly reduce arterial stiffness. At present, all techniques that assess arterial stiffness should be considered primarily research tools not ready for immediate clinical application (23 25). REFERENCES 1. Kannel WB, Gordon T, Schwartz MJ. Systolic vs diastolic blood pressure and risk of coronary heart disease. Am J Cardiol 1971;27: Izzo JL Jr, Levy D, Black HR. Clinical advisory statement: importance of systolic blood pressure in older Americans. Hypertension 2000;35: Franklin SS, Jacobs MJ, Wong ND, L Italien GJ, Lapuerta P. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension 2001;37: Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure JNC VII Express. JAMA 2003;289: Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, Hypertension 1995;25: Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360: Franklin SS, Khan SA, Wong ND, Larson MG, Levy D. Is pulse pressure more important than systolic blood pressure in predicting coronary heart disease events. Circulation 1999;100: Mitchell GF, Moye LA, Braunwald E, et al. Sphygmomanometrically determined pulse pressure is a powerful independent predictor of recurrent events after myocar-
12 34 Hypertension in the Elderly dial infarction in patients with impaired left ventricular function. Circulation 1997;96: Blacher J, London GM, Safar ME, Mourad JJ. Influence of age and end-stage renal disease on the stiffness of carotid wall material in hypertension. J Hypertens 1999;17: Asmar R, Rudnichi A, Blacher J, London GM, Safar ME. Pulse pressure and aortic pulse wave are markers of cardiovascular risk in hypertensive populations. Am J Hypertension 2001;14: Lloyd-Jones DM. Impact of systolic vs diastolic blood pressure level of JNC-VI blood pressure stage classification. Hypertension 1999;34: SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older patients with isolated systolic hypertension. JAMA 1991;265: Staessen JA, Fagard R, Thijs L, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997;350: Staessen JA, Wang JG, Thijs L, Fagard R. Overview of the outcome trials in older patients with isolated systolic hypertension. J Hum Hypertens 1999;13: Fagard RH, Staessen JA, Thijs L, et al. Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Circulation 2000;102: Julius S, Krause L, Schork NJ, et al. Hyperkinetic borderline hypertension in Tecumseh, Michigan. J Hypertens 1991;9: Asmar R. Arterial pulse waves. In: Asmar R, ed. Arterial stiffness and pulse wave velocity: clinical applications. Amsterdam: Elsevier; 1999: Nichols WW, O Rourke MF. McDonald s blood flow in arteries: theoretical, experimental and clinical principles. 4th ed. London: Arnold; 1998: Wilkinson IB, Franklin SS, Hall IR, Tyrrell S, Cockcroft JR. Pressure amplification explains why pulse pressure is unrelated to risk in young subjects. Hypertension 2001;38: Koch-Weser J. Correlation of pathophysiology and pharmacology in primary hypertension. Am J Cardiol 1973;32: Blacher J, Asmar R, Djane S, London GM, Safar ME. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 1999;33: Mitchell GF, Izzo JL Jr, Lacourciere Y, et al. Omapatrilat reduces pulse pressure and proximal aortic stiffness in patients with systolic hypertension: results of the conduit hemodynamics of omapatrilat international research study. Circulation 2002;105: Izzo JL Jr, Shykoff BE. Arterial stiffness: clinical relevance, measurement, and treatment. Rev Cardiovasc Med 2001;2:29 34, Izzo JL Jr, Manning TS, Shykoff BE. Office blood pressures, arterial compliance characteristics, and estimated cardiac load. Hypertension 2001;38: Manning TS, Shykoff BE, Izzo JL Jr. Validity and reliability of diastolic pulse contour analysis (windkessel model) in humans. Hypertension 2002;39: Williams TF, Foerster JE, Proctor JK, Hahn A, Izzo AJ, Elliott GA. A new doublelayered launderable bed sheet for patients with urinary incontinence. J Am Geriatr Soc 1981;29: Nichols WW, et al. Arterial vasodilation. Philadelphia; 1993: Fleg/Kelly. Hypertension primer.
Clinical application of Arterial stiffness. pulse wave analysis pulse wave velocity
Clinical application of Arterial stiffness pulse wave analysis pulse wave velocity Arterial system 1. Large arteries: elastic arteries Aorta, carotid, iliac, Buffering reserve: store blood during systole
More informationChanges in Blood Pressure and Vascular Physiology: Markers for Cardiovascular Disease
...SYMPOSIUM PROCEEDINGS... Changes in Blood Pressure and Vascular Physiology: Markers for Cardiovascular Disease Based on a presentation by Joseph L. Izzo, Jr., MD Presentation Summary Changes in systolic
More informationDirector of the Israeli Institute for Quality in Medicine Israeli Medical Association July 1st, 2016
The differential effect of Atherosclerosis on end organ damage in adult and elderly patients with CVRF: New Algorithm for Hypertension Diagnosis and Treatment R. Zimlichman, FAHA, FASH, FESC, FESH Chief
More information47 Hypertension in Elderly
47 Hypertension in Elderly YOU DO NOT HEAL OLD AGE; YOU PROTECT IT; YOU PROMOTE IT; YOU EXTEND IT Sir James Sterling Ross Abstract: The prevalence of hypertension rises with age and the complications secondary
More informationPulse pressure as a haemodynamic variable in systolic heart failure Petrie, Colin James
University of Groningen Pulse pressure as a haemodynamic variable in systolic heart failure Petrie, Colin James IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you
More informationEffects of Renin-Angiotensin System blockade on arterial stiffness and function. Gérard M. LONDON Manhès Hospital Paris, France
Effects of Renin-Angiotensin System blockade on arterial stiffness and function Gérard M. LONDON Manhès Hospital Paris, France Determinants of vascular overload (afterload) on the heart Peripheral Resistance
More informationHTA ET DIALYSE DR ALAIN GUERIN
HTA ET DIALYSE DR ALAIN GUERIN Cardiovascular Disease Mortality General Population vs ESRD Dialysis Patients 100 Annual CVD Mortality (%) 10 1 0.1 0.01 0.001 25-34 35-44 45-54 55-64 66-74 75-84 >85 Age
More informationTODAY S TOPIC Blood Pressure & Pulse Wave Measurement Combined in One Procedure Re-classification of Risk Patients
CARDIOVASCULAR TECHNOLOGY AND INDICATION SERVICE TODAY S TOPIC Blood Pressure & Pulse Wave Measurement Combined in One Procedure Re-classification of Risk Patients SERIES Hypertension Management in the
More informationArterial stiffness and central BP as goals for antihypertensive therapy in pre- and elderly. Piotr Jankowski
Arterial stiffness and central BP as goals for antihypertensive therapy in pre- and elderly Piotr Jankowski I Department of Cardiology and Hypertension CM UJ, Kraków, Poland piotrjankowski@interia.pl Vienna,
More informationCan Arterial Stiffness Be Reversed? And If So, What Are the Benefits?
...SYMPOSIUM PROCEEDINGS... Can Arterial Stiffness Be Reversed? And If So, What Are the Benefits? Based on a presentation by Michel E. Safar, MD Presentation Summary Systolic and diastolic blood pressure
More informationArterial Pressure in CKD5 - ESRD Population Gérard M. London
Arterial Pressure in CKD5 - ESRD Population Gérard M. London INSERM U970 Paris 150 SBP & DBP by Age, Ethnicity &Gender (US Population Age 18 Years, NHANES III) 150 SBP (mm Hg) 130 110 80 Non-Hispanic Black
More informationWhen should you treat blood pressure in the young?
ESC Stockholm - Dilemmas in Cardiovascular Disease Prevention in the Young: 30 th August 2010 When should you treat blood pressure in the young? Bryan Williams MD FRCP FAHA FESC Professor of Medicine Department
More informationWhich method is better to measure arterial stiffness; augmentation index, pulse wave velocity, carotid distensibility? 전북의대내과 김원호
Which method is better to measure arterial stiffness; augmentation index, pulse wave velocity, carotid distensibility? 전북의대내과 김원호 Arterial stiffness Arterial stiffness is inversely related to arterial
More informationThe Conduit Artery Functional Endpoint (CAFE) study in ASCOT
(2001) 15, Suppl 1, S69 S73 2001 Nature Publishing Group All rights reserved 0950-9240/01 $15.00 www.nature.com/jhh A Sub-study of the ASCOT Trial The Conduit Artery Functional Endpoint (CAFE) study in
More informationPreventing heart disease by controlling hypertension: Impact of hypertensive subtype, stage, age, and sex
Prevention and Rehabilitation Preventing heart disease by controlling hypertension: Impact of hypertensive subtype, stage, age, and sex Nathan D. Wong, PhD, a Gaurav Thakral, BS, a Stanley S. Franklin,
More informationChapter 01. General introduction and outline
Chapter 01 General introduction and outline General introduction and outline Introduction Cardiovascular disease is the main cause of death in patients with hypertension and in patients with type-1 diabetes
More informationIsolated Systolic Hypertension in the elderly. Daniel Hayoz Clinique de Médecine Interne HFR-Hôpital Cantonal Fribourg
Isolated Systolic Hypertension in the elderly Daniel Hayoz Clinique de Médecine Interne HFR-Hôpital Cantonal Fribourg Case no 1 Man aged 75, from Kosovo, in CH since 1.5 years Former smoker (45 PY) BP:
More informationT. Suithichaiyakul Cardiomed Chula
T. Suithichaiyakul Cardiomed Chula The cardiovascular (CV) continuum: role of risk factors Endothelial Dysfunction Atherosclerosis and left ventricular hypertrophy Myocardial infarction & stroke Endothelial
More informationImpedance Cardiography (ICG) Application of ICG for Hypertension Management
Application of ICG for Hypertension Management 1mA @ 100 khz Impedance Cardiography (ICG) Non-invasive Beat-to-beat Hemodynamic Monitoring Diastole Systole Aortic valve is closed No blood flow in the aorta
More informationCVS Hemodynamics. Faisal I. Mohammed, MD,PhD.
CVS Hemodynamics Faisal I. Mohammed, MD,PhD. Objectives point out the physical characteristics of the circulation: distribution of blood volume total cross sectional area velocity blood pressure List the
More informationSystolic Hypertension in the Elderly: Addressing an Unmet Need
REVIEW Systolic Hypertension in the Elderly: Addressing an Unmet Need Daniel A. Duprez, MD, PhD Cardiovascular Division, Medical School, University of Minnesota, Minn. ABSTRACT Systolic hypertension is
More information...SELECTED ABSTRACTS...
The following abstracts, from peer-reviewed journals containing literature on vascular compliance and hypertension, were selected for their relevance to this conference and to a managed care perspective.
More informationBased on epidemiologic studies associating the. Systolic Blood Pressure. Itʼs Time to Take Control. Stanley S. Franklin
AJH 2004; 17:49S 54S Systolic Blood Pressure Itʼs Time to Take Control Stanley S. Franklin Once considered an inconsequential part of the aging process, an age-associated rise in systolic blood pressure
More informationThe Effect of Isosorbide Dinitrate Intravenous Injection on the Hemodynamics and Arterial Stiffness of Patients with Isolated Systolic Hypertension
Original ORIGINAL Article ARTICLE Korean Circulation J 2007;37:359-364 ISSN 1738-5520 c 2007, The Korean Society of Circulation The Effect of Isosorbide Dinitrate Intravenous Injection on the Hemodynamics
More informationInt. J. Pharm. Sci. Rev. Res., 36(1), January February 2016; Article No. 06, Pages: JNC 8 versus JNC 7 Understanding the Evidences
Research Article JNC 8 versus JNC 7 Understanding the Evidences Anns Clara Joseph, Karthik MS, Sivasakthi R, Venkatanarayanan R, Sam Johnson Udaya Chander J* RVS College of Pharmaceutical Sciences, Coimbatore,
More informationNomogram of the Relation of Brachial-Ankle Pulse Wave Velocity with Blood Pressure
801 Original Article Nomogram of the Relation of Brachial-Ankle Pulse Wave Velocity with Blood Pressure Akira YAMASHINA, Hirofumi TOMIYAMA, Tomio ARAI, Yutaka KOJI, Minoru YAMBE, Hiroaki MOTOBE, Zydem
More informationThe arterial system has a dual function:
Hellenic J Cardiol 2010; 51: 385-390 Editorial Aortic Stiffness: Prime Time for Integration into Clinical Practice? Charalambos Vlachopoulos, Nikolaos Alexopoulos, Christodoulos Stefanadis Peripheral Vessels
More informationArterial Stiffness: pathophysiology and clinical impact. Gérard M. LONDON Manhès Hospital Fleury-Mérogis/Paris, France
Arterial Stiffness: pathophysiology and clinical impact Gérard M. LONDON Manhès Hospital Fleury-Mérogis/Paris, France Determinants of vascular overload (afterload) on the heart Peripheral Resistance Arterial
More informationVascular disease. Structural evaluation of vascular disease. Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital
Vascular disease. Structural evaluation of vascular disease Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital resistance vessels : arteries
More informationDepartments of Cardiology and Vascular Surgery Michaelidion Cardiac Center University of Ioannina, Greece
Departments of Cardiology and Vascular Surgery Michaelidion Cardiac Center University of Ioannina, Greece ARGYRIS Vassilis, PEROULIS Michalis, MATSAGKAS Miltiadis, BECHLIOULIS Aris, MICHALIS Lampros, NAKA
More informationCentral Pressures and Prehypertension
Central Pressures and Prehypertension Charalambos Vlachopoulos Associate Professor of Cardiology 1 st Cardiology Dept Athens Medical School Central Pressures and Prehypertension Charalambos Vlachopoulos
More informationEffects of coexisting hypertension and type II diabetes mellitus on arterial stiffness
(2004) 18, 469 473 & 2004 Nature Publishing Group All rights reserved 0950-9240/04 $30.00 www.nature.com/jhh ORIGINAL ARTICLE Effects of coexisting hypertension and type II diabetes mellitus on arterial
More informationShould beta blockers remain first-line drugs for hypertension?
1 de 6 03/11/2008 13:23 Should beta blockers remain first-line drugs for hypertension? Maros Elsik, Cardiologist, Department of Epidemiology and Preventive Medicine, Monash University and The Alfred Hospital,
More informationDetermination of age-related increases in large artery stiffness by digital pulse contour analysis
Clinical Science (2002) 103, 371 377 (Printed in Great Britain) 371 Determination of age-related increases in large artery stiffness by digital pulse contour analysis S. C. MILLASSEAU, R. P. KELLY, J.
More informationA comparison of diabetic and nondiabetic subjects
Pathophysiology/Complications O R I G I N A L A R T I C L E The Aging of Elastic and Muscular Arteries A comparison of diabetic and nondiabetic subjects JAMES D. CAMERON, MD, MENGSC 1 CHRISTOPHER J. BULPITT,
More informationBIPN100 F15 Human Physiol I (Kristan) Lecture 14 Cardiovascular control mechanisms p. 1
BIPN100 F15 Human Physiol I (Kristan) Lecture 14 Cardiovascular control mechanisms p. 1 Terms you should understand: hemorrhage, intrinsic and extrinsic mechanisms, anoxia, myocardial contractility, residual
More informationManaging HTN in the Elderly: How Low to Go
Managing HTN in the Elderly: How Low to Go Laxmi S. Mehta, MD, FACC The Ohio State University Medical Center Assistant Professor of Clinical Internal Medicine Clinical Director of the Women s Cardiovascular
More informationOverview of the outcome trials in older patients with isolated systolic hypertension
Journal of Human Hypertension (1999) 13, 859 863 1999 Stockton Press. All rights reserved 0950-9240/99 $15.00 http://www.stockton-press.co.uk/jhh Overview of the outcome trials in older patients with isolated
More informationPrevalence of Comorbidities and Their Influence on Blood Pressure Goal Attainment in Geriatric Patients
Original Paper Prevalence of Comorbidities and Their Influence on Blood Pressure Goal Attainment in Geriatric Patients CME Credit 1 www.lejacq.com/cme John D. Bisognano, MD, PhD; 1 Kevin A. Townsend, MS,
More informationΗ σημασία της αρτηριακής σκληρίας στην εκτίμηση της διαστολικής δυσλειτουργίας στην υπέρταση. Θεραπευτικές παρεμβάσεις
Η σημασία της αρτηριακής σκληρίας στην εκτίμηση της διαστολικής δυσλειτουργίας στην υπέρταση. Θεραπευτικές παρεμβάσεις Ελένη Τριανταφυλλίδη Επιμελήτρια Α Β Πανεπιστημιακή Καρδιολογική Κλινική Αττικό Νοσοκομείο
More informationDiastolic hypertension, defined as a diastolic blood pressure
Hypertension Predictors of New-Onset Diastolic and Systolic Hypertension The Framingham Heart Study Stanley S. Franklin, MD; Jose R. Pio, BS; Nathan D. Wong, PhD; Martin G. Larson, ScD; Eric P. Leip, MS;
More informationBlood Pressure Response Under Chronic Antihypertensive Drug Therapy
Journal of the American College of Cardiology Vol. 53, No. 5, 29 29 by the American College of Cardiology Foundation ISSN 735-197/9/$36. Published by Elsevier Inc. doi:1.116/j.jacc.28.9.46 Hypertension
More informationWhat s In the New Hypertension Guidelines?
American College of Physicians Ohio/Air Force Chapters 2018 Scientific Meeting Columbus, OH October 5, 2018 What s In the New Hypertension Guidelines? Max C. Reif, MD, FACP Objectives: At the end of the
More informationSpecial Lecture 10/28/2012
Special Lecture 10/28/2012 HYPERTENSION Dr. HN Mayrovitz Special Lecture 10/28/2012 Arterial Blood Pressure (ABP) - Definitions ABP Review Indirect Oscillographic Method Resistance (R), Compliance (C)
More informationPreventing Early Vascular Ageing (EVA) and its hemodynamic changes
Translational Research 31 st October 2013, Moscow Preventing Early Vascular Ageing (EVA) and its hemodynamic changes Peter M Nilsson, MD, PhD Department of Clinical Sciences Lund University University
More informationThe Arterial and Venous Systems Roland Pittman, Ph.D.
The Arterial and Venous Systems Roland Pittman, Ph.D. OBJECTIVES: 1. State the primary characteristics of the arterial and venous systems. 2. Describe the elastic properties of arteries in terms of pressure,
More informationSlide notes: References:
1 2 3 Cut-off values for the definition of hypertension are systolic blood pressure (SBP) 135 and/or diastolic blood pressure (DBP) 85 mmhg for home blood pressure monitoring (HBPM) and daytime ambulatory
More informationHypertension in the Elderly. John Puxty Division of Geriatrics Center for Studies in Aging and Health, Providence Care
Hypertension in the Elderly John Puxty Division of Geriatrics Center for Studies in Aging and Health, Providence Care Learning Objectives Review evidence for treatment of hypertension in elderly Consider
More informationMeasurement of Arterial Stiffness: Why should I measure both PWA and PWV?
Measurement of Arterial Stiffness: Why should I measure both PWA and PWV? Central blood pressure and measures of arterial stiffness have been shown to be powerful predictors of major cardiovascular events,
More informationHYPERTENSION AND HEART FAILURE
HYPERTENSION AND HEART FAILURE Kenya Cardiac Society Symposium Feb 2017 Dr Jeilan Mohamed No conflict of interests . Geoffrey, 45 yr old hypertensive office worker male from Nairobi, has just watched his
More informationASSOCIATION OF SYSTEMIC INFLAMMATION WITH ARTERIAL STIFFNESS IN HYPERTENSION
ASSOCIATION OF SYSTEMIC INFLAMMATION WITH ARTERIAL STIFFNESS IN HYPERTENSION Jung-Sun Kim a and Sungha Park a,b, a Division of Cardiology, b Cardiovascular Genome Center, Yonsei Cardiovascular Center,
More informationSelected age-associated changes in the cardiovascular system
Selected age-associated changes in the cardiovascular system Tamara Harris, M.D., M.S. Chief, Interdisciplinary Studies of Aging Acting Co-Chief, Laboratory of Epidemiology and Population Sciences Intramural
More informationSpecial Lecture 11/08/2013. Hypertension Dr. HN Mayrovitz
Special Lecture 11/08/2013 Hypertension Dr. HN Mayrovitz Arterial Blood Pressure (ABP) Major Factors Summarized Sympathetic Hormones Arteriole MAP ~ Q x TPR + f (V / C) SV x HR Renal SBP Hypertension =
More informationPathophysiology of Vascular Function in CKD. INSERM U970 Hôpital Européen Georges Pompidou Paris
Pathophysiology of Vascular Function in CKD Gérard M. London INSERM U970 Hôpital Européen Georges Pompidou Paris Arterial Pathophysiology and Cardiovascular Diseases in CKD Systolic BP; Diastolic BP Arteriosclerosis
More informationLeft ventricular hypertrophy: why does it happen?
Nephrol Dial Transplant (2003) 18 [Suppl 8]: viii2 viii6 DOI: 10.1093/ndt/gfg1083 Left ventricular hypertrophy: why does it happen? Gerard M. London Department of Nephrology and Dialysis, Manhes Hospital,
More informationBenefits from angiotensin-converting enzyme inhibition in patients with renal failure: latest results
European Heart Journal Supplements (2003) 5 (Supplement E), E18 E22 Benefits from angiotensin-converting enzyme inhibition in patients with renal failure: latest results B. Pannier, A.P. Guérin, S.J. Marchais
More informationManaging hypertension: a question of STRATHE
(2005) 19, S3 S7 & 2005 Nature Publishing Group All rights reserved 0950-9240/05 $30.00 www.nature.com/jhh ORIGINAL ARTICLE Managing hypertension: a question of STRATHE Department of Cardiovascular Disease,
More informationClinical usefulness of the second peak of radial systolic blood pressure for estimation of aortic systolic blood pressure
(2009) 23, 538 545 & 2009 Macmillan Publishers Limited All rights reserved 0950-9240/09 $32.00 www.nature.com/jhh ORIGINAL ARTICLE Clinical usefulness of the second peak of radial systolic blood pressure
More information9 STUDY OF PR INTERVAL IN FEMALES OF DIFFERENT AGE GROUPS Swati Jangam 1,Manjunatha S 2, Vijaynath 3, Veena H C 4 1: Assistant nprofessor, department
9 STUDY OF PR INTERVAL IN FEMALES OF DIFFERENT AGE GROUPS Swati Jangam 1,Manjunatha S 2, Vijaynath 3, Veena H C 4 1: Assistant nprofessor, department of Physiology, Khaja Banda Nawaz institute of Medical
More informationEffects of Kidney Disease on Cardiovascular Morbidity and Mortality
Effects of Kidney Disease on Cardiovascular Morbidity and Mortality Joachim H. Ix, MD, MAS Assistant Professor in Residence Division of Nephrology University of California San Diego, and Veterans Affairs
More informationHypertension: What s new since JNC 7. Harold M. Szerlip, MD, FACP, FCCP, FASN, FNKF
Hypertension: What s new since JNC 7 Harold M. Szerlip, MD, FACP, FCCP, FASN, FNKF Disclosures Spectral Diagnostics Site investigator Eli Lilly Site investigator ACP IM ITE writing committee NBME Step
More informationThe organs of the human body were created to perform ten functions among which is the function of the kidney to furnish the human being with thought.
The organs of the human body were created to perform ten functions among which is the function of the kidney to furnish the human being with thought. Leviticus Rabba 3 Talmud Berochoth 6 1 b Outline &
More informationAge-related changes in cardiovascular system. Dr. Rehab Gwada
Age-related changes in cardiovascular system Dr. Rehab Gwada Objectives explain the main structural and functional changes in cardiovascular system associated with normal aging Introduction aging results
More informationa Centre d Investigations Préventives et Cliniques, b Hypertension and Received 18 July 2007 Revised 11 February 2008 Accepted 13 February 2008
1072 Original article Cardiovascular risk as defined in the 2003 European blood pressure classification: the assessment of an additional predictive value of pulse pressure on mortality Frédérique Thomas
More informationWhat is the mechanism of the audible carotid bruit? How does one calculate the velocity of blood flow?
CASE 8 A 65-year-old man with a history of hypertension and coronary artery disease presents to the emergency center with complaints of left-sided facial numbness and weakness. His blood pressure is normal,
More information2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension.
2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension Writing Group: Background Hypertension worldwide causes 7.1 million premature
More informationAssessment of Arterials Functions: Is Pulse Wave Velocity ready forprime Time. Gérard M. LONDON INSERM U970 Hopital Georges Pompidou Paris, France
Assessment of Arterials Functions: Is Pulse Wave Velocity ready forprime Time Gérard M. LONDON INSERM U970 Hopital Georges Pompidou Paris, France The causes of Cardiovascular Diseases in CKD Systolic BP;
More informationUsing the New Hypertension Guidelines
Using the New Hypertension Guidelines Kamal Henderson, MD Department of Cardiology, Preventive Medicine, University of North Carolina School of Medicine Kotchen TA. Historical trends and milestones in
More informationThe Cardiac Cycle Clive M. Baumgarten, Ph.D.
The Cardiac Cycle Clive M. Baumgarten, Ph.D. OBJECTIVES: 1. Describe periods comprising cardiac cycle and events within each period 2. Describe the temporal relationships between pressure, blood flow,
More informationCardiac Cycle MCQ. Professor of Cardiovascular Physiology. Cairo University 2007
Cardiac Cycle MCQ Abdel Moniem Ibrahim Ahmed, MD Professor of Cardiovascular Physiology Cairo University 2007 1- Regarding the length of systole and diastole: a- At heart rate 75 b/min, the duration of
More informationΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ. Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH
ΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH Hypertension Co-Morbidities HTN Commonly Clusters with Other Risk
More informationJNC Evidence-Based Guidelines for the Management of High Blood Pressure in Adults
JNC 8 2014 Evidence-Based Guidelines for the Management of High Blood Pressure in Adults Table of Contents Why Do We Treat Hypertension? Blood Pressure Treatment Goals Initial Therapy Strength of Recommendation
More informationTouyz, R. M., and Dominiczak, A. F. (2016) Hypertension guidelines: is it time to reappraise blood pressure thresholds and targets? Hypertension, 67(4), pp. 688-689. There may be differences between this
More informationAcute Effect of Resistance Exercise on Vascular and Cognitive Function
Syracuse University SURFACE Syracuse University Honors Program Capstone Projects Syracuse University Honors Program Capstone Projects Spring 5-2016 Acute Effect of Resistance Exercise on Vascular and Cognitive
More informationCVS Hemodynamics. Change in blood pressure:
CVS Hemodynamics -The distribution of blood inside the circulation: The major part of blood volume is found in the venous system 60% (2/3), that s why veins are called the capacitance vessels. -Arteries
More informationPhysiologic Based Management of Circulatory Shock Kuwait 2018
Physiologic Based Management of Circulatory Shock Kuwait 2018 Dr. Yasser Elsayed, MD, PhD Director of the Targeted Neonatal Echocardiography, Point of Care and Hemodynamics Program Staff Neonatologist
More informationHYPERTENSION GUIDELINES WHERE ARE WE IN 2014
HYPERTENSION GUIDELINES WHERE ARE WE IN 2014 Donald J. DiPette MD FACP Special Assistant to the Provost for Health Affairs Distinguished Health Sciences Professor University of South Carolina University
More informationUpdate in Hypertension
Update in Hypertension Eliseo J. PérezP rez-stable MD Professor of Medicine DGIM, Department of Medicine UCSF 20 May 2008 Declaration of full disclosure: No conflict of interest (I have never been funded
More informationMANAGEMENT OF HYPERTENSION: TREATMENT THRESHOLDS AND MEDICATION SELECTION
Management of Hypertension: Treatment Thresholds and Medication Selection Robert B. Baron, MD MS Professor and Associate Dean Declaration of full disclosure: No conflict of interest Presentation Goals
More informationLab Period: Name: Physiology Chapter 14 Blood Flow and Blood Pressure, Plus Fun Review Study Guide
Lab Period: Name: Physiology Chapter 14 Blood Flow and Blood Pressure, Plus Fun Review Study Guide Main Idea: The function of the circulatory system is to maintain adequate blood flow to all tissues. Clinical
More informationCover Page. The handle holds various files of this Leiden University dissertation
Cover Page The handle http://hdl.handle.net/1887/28524 holds various files of this Leiden University dissertation Author: Djaberi, Roxana Title: Cardiovascular risk assessment in diabetes Issue Date: 2014-09-04
More informationThe reproducibility of central aortic blood pressure measurements in healthy subjects using applanation tonometry and sphygmocardiography
Journal of Human Hypertension (1999) 13, 625 629 1999 Stockton Press. All rights reserved 0950-9240/99 $15.00 http://www.stockton-press.co.uk/jhh ORIGINAL ARTICLE The reproducibility of central aortic
More informationStudy of Serum Uric Acid Level in Hypertension
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 16, Issue 4 Ver. VI (April. 2017), PP 69-73 www.iosrjournals.org Study of Serum Uric Acid Level in Hypertension
More informationCollin County Community College
Collin County Community College BIOL. 2402 Anatomy & Physiology WEEK 6 Blood Vessels 1 Anatomy of Blood Vessels Walls of blood vessels contain 3 distinct layers : Tunica intima innermost layer includes
More informationTheoretical and practical questions in the evaluation of arterial function Miklós Illyés MD. Ph.D.
Theoretical and practical questions in the evaluation of arterial function Miklós Illyés MD. Ph.D. TensioMed Arterial Stiffness Centre, Budapest Heart Institute, Faculty of Medicine, University of Pécs
More informationDespite the acknowledged importance of hypertension as
Does the Relation of Blood Pressure to Coronary Heart Disease Risk Change With Aging? The Framingham Heart Study Stanley S. Franklin, MD; Martin G. Larson, ScD; Shehzad A. Khan, BS; Nathan D. Wong, PhD;
More informationDynamic measures of arterial stiffness in a rodent model
Dynamic measures of arterial stiffness in a rodent model A Thesis Submitted to the College of Graduate Studies and Research in Partial Fulfillment of the Requirements for the degree of Master of Science
More informationLarge therapeutic studies in elderly patients with hypertension
(2002) 16 (Suppl 1), S38 S43 2002 Nature Publishing Group All rights reserved 0950-9240/02 $25.00 www.nature.com/jhh Large therapeutic studies in elderly patients with hypertension Centro Clinico Profesional
More informationAllopurinol reduces left ventricular hypertrophy and endothelial dysfunction in patients with chronic kidney disease
Allopurinol reduces left ventricular hypertrophy and endothelial dysfunction in patients with chronic kidney disease Michelle P Kao, Donald S Ang, Steve Gandy, Chim C Lang, Allan D Struthers Division of
More informationBlood pressure (BP) is an established major risk factor for
Pulse Pressure Compared With Other Blood Pressure Indexes in the Prediction of 25-Year Cardiovascular and All-Cause Mortality Rates The Chicago Heart Association Detection Project in Industry Study Katsuyuki
More informationOsama Sanad (MD) Prof. of Cardiology Benha University 2016
Osama Sanad (MD) Prof. of Cardiology Benha University 2016 Back in time. 1912 Back in time. 1912 No body knows that hypertension is a lethal disease Hypertension in 1940s Among anti-hypertensives mentioned
More informationVital Signs. Vital Signs. Pulse. Temperature. Respiration. Blood Pressure
Vital Signs Jarvis, Chapter 9 Vital Signs Classic Vital Signs TPR/BP Temperature Pulse Respirations Blood Pressure Additional Vital Signs Height Weight BMI (Kg/m2) or (702Xlbs/in2) Supine, orthostatic
More informationHypertension Update Clinical Controversies Regarding Age and Race
Hypertension Update Clinical Controversies Regarding Age and Race Allison Helmer, PharmD, BCACP Assistant Clinical Professor Auburn University Harrison School of Pharmacy July 22, 2017 DISCLOSURE/CONFLICT
More informationResearch Article The Age-Dependent Contribution of Aortic Incident and Reflected Pressure Waves to Central Blood Pressure in African-Americans
SAGE-Hindawi Access to Research International Hypertension Volume 211, Article ID 58573, 6 pages doi:1.461/211/58573 Research Article The Age-Dependent Contribution of Aortic Incident and Reflected Pressure
More informationClinical Updates in the Treatment of Hypertension JNC 7 vs. JNC 8. Lauren Thomas, PharmD PGY1 Pharmacy Practice Resident South Pointe Hospital
Clinical Updates in the Treatment of Hypertension JNC 7 vs. JNC 8 Lauren Thomas, PharmD PGY1 Pharmacy Practice Resident South Pointe Hospital Objectives Review the Eighth Joint National Committee (JNC
More informationChapter 13 The Cardiovascular System: Cardiac Function
Chapter 13 The Cardiovascular System: Cardiac Function Overview of the Cardiovascular System The Path of Blood Flow through the Heart and Vasculature Anatomy of the Heart Electrical Activity of the Heart
More informationIS PVR THE RIGHT METRIC FOR RV AFTERLOAD?
Echo Doppler Assessment of PVR The Children s Hospital Denver, CO Robin Shandas Professor of Pediatrics, Cardiology Professor of Mechanical Engineering Director, Center for Bioengineering University of
More informationEstrogens vs Testosterone for cardiovascular health and longevity
Estrogens vs Testosterone for cardiovascular health and longevity Panagiota Pietri, MD, PhD, FESC Director of Hypertension Unit Athens Medical Center Athens, Greece Women vs Men Is there a difference in
More informationAN EARLY WARNING SYSTEM FOR CARDIOVASCULAR DISEASE
AN EARLY WARNING SYSTEM FOR CARDIOVASCULAR DISEASE Good for your patients. Good for your practice. Using the AngioDefender system to complement your patients care routine enables you to: Improve your patient
More information